

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | short-term memory (GO:0007614) | 9.67822280 |
| 2 | skeletal muscle contraction (GO:0003009) | 9.39128110 |
| 3 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 9.37771313 |
| 4 | skeletal muscle adaptation (GO:0043501) | 8.75083435 |
| 5 | actin-mediated cell contraction (GO:0070252) | 8.48872372 |
| 6 | skeletal muscle fiber development (GO:0048741) | 7.38966191 |
| 7 | cerebellar Purkinje cell differentiation (GO:0021702) | 7.23543247 |
| 8 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.08010748 |
| 9 | cerebellar Purkinje cell layer development (GO:0021680) | 6.84105089 |
| 10 | neuronal action potential propagation (GO:0019227) | 6.77171263 |
| 11 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 6.50983092 |
| 12 | actin filament-based movement (GO:0030048) | 6.36128991 |
| 13 | myotube cell development (GO:0014904) | 6.29346940 |
| 14 | fructose metabolic process (GO:0006000) | 6.28131686 |
| 15 | glycogen catabolic process (GO:0005980) | 6.14854099 |
| 16 | cell differentiation in hindbrain (GO:0021533) | 6.14174644 |
| 17 | C4-dicarboxylate transport (GO:0015740) | 6.09777436 |
| 18 | striated muscle contraction (GO:0006941) | 5.95640139 |
| 19 | protein heterotetramerization (GO:0051290) | 5.90224886 |
| 20 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.89147841 |
| 21 | metanephric nephron tubule development (GO:0072234) | 5.84899793 |
| 22 | metanephric tubule development (GO:0072170) | 5.84899793 |
| 23 | prepulse inhibition (GO:0060134) | 5.82444764 |
| 24 | plasma membrane repair (GO:0001778) | 5.81630387 |
| 25 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 5.80851690 |
| 26 | regulation of cell communication by electrical coupling (GO:0010649) | 5.79461038 |
| 27 | cellular sodium ion homeostasis (GO:0006883) | 5.75704987 |
| 28 | glucan catabolic process (GO:0009251) | 5.75032493 |
| 29 | creatine metabolic process (GO:0006600) | 5.73702612 |
| 30 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.72881063 |
| 31 | sodium ion export (GO:0071436) | 5.70148443 |
| 32 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.57471249 |
| 33 | metanephric nephron epithelium development (GO:0072243) | 5.46119789 |
| 34 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.44950466 |
| 35 | cellular polysaccharide catabolic process (GO:0044247) | 5.32695631 |
| 36 | collecting duct development (GO:0072044) | 5.31620870 |
| 37 | neurofilament cytoskeleton organization (GO:0060052) | 5.30555111 |
| 38 | response to histamine (GO:0034776) | 5.29416714 |
| 39 | neuron-neuron synaptic transmission (GO:0007270) | 5.28767715 |
| 40 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 5.23668391 |
| 41 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 5.21748217 |
| 42 | positive regulation of muscle hypertrophy (GO:0014742) | 5.21748217 |
| 43 | glutamate receptor signaling pathway (GO:0007215) | 5.17920130 |
| 44 | skeletal muscle tissue regeneration (GO:0043403) | 5.16165727 |
| 45 | sarcomere organization (GO:0045214) | 5.12923024 |
| 46 | polysaccharide catabolic process (GO:0000272) | 5.09367497 |
| 47 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 5.02162638 |
| 48 | purine nucleotide salvage (GO:0032261) | 5.00929015 |
| 49 | striated muscle atrophy (GO:0014891) | 5.00381726 |
| 50 | metanephric epithelium development (GO:0072207) | 5.00257685 |
| 51 | musculoskeletal movement (GO:0050881) | 4.96994052 |
| 52 | multicellular organismal movement (GO:0050879) | 4.96994052 |
| 53 | response to muscle activity (GO:0014850) | 4.93234894 |
| 54 | synaptic transmission, glutamatergic (GO:0035249) | 4.92753496 |
| 55 | carnitine shuttle (GO:0006853) | 4.89581524 |
| 56 | inositol phosphate-mediated signaling (GO:0048016) | 4.89542387 |
| 57 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.89487456 |
| 58 | muscle contraction (GO:0006936) | 4.83126783 |
| 59 | relaxation of smooth muscle (GO:0044557) | 4.81855919 |
| 60 | aggressive behavior (GO:0002118) | 4.77295265 |
| 61 | response to inactivity (GO:0014854) | 4.71455039 |
| 62 | myofibril assembly (GO:0030239) | 4.68898141 |
| 63 | striated muscle adaptation (GO:0014888) | 4.61223390 |
| 64 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.55666824 |
| 65 | neuromuscular synaptic transmission (GO:0007274) | 4.53666242 |
| 66 | cytidine metabolic process (GO:0046087) | 4.50027516 |
| 67 | cytidine catabolic process (GO:0006216) | 4.50027516 |
| 68 | cytidine deamination (GO:0009972) | 4.50027516 |
| 69 | glucan biosynthetic process (GO:0009250) | 4.48429300 |
| 70 | glycogen biosynthetic process (GO:0005978) | 4.48429300 |
| 71 | muscle fiber development (GO:0048747) | 4.44124754 |
| 72 | retina layer formation (GO:0010842) | 4.41158241 |
| 73 | muscle atrophy (GO:0014889) | 4.37398105 |
| 74 | negative regulation of heart rate (GO:0010459) | 4.36000998 |
| 75 | muscle system process (GO:0003012) | 4.32265942 |
| 76 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.26058650 |
| 77 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.25712099 |
| 78 | negative regulation of norepinephrine secretion (GO:0010700) | 4.16856806 |
| 79 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 4.15277157 |
| 80 | glycogen metabolic process (GO:0005977) | 4.08037655 |
| 81 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.07840088 |
| 82 | behavioral response to nicotine (GO:0035095) | 4.07312028 |
| 83 | fatty acid transmembrane transport (GO:1902001) | 4.04961302 |
| 84 | chemosensory behavior (GO:0007635) | 4.04462713 |
| 85 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.00815594 |
| 86 | cellular glucan metabolic process (GO:0006073) | 3.99642104 |
| 87 | glucan metabolic process (GO:0044042) | 3.99642104 |
| 88 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.98313837 |
| 89 | IMP metabolic process (GO:0046040) | 3.98123502 |
| 90 | relaxation of cardiac muscle (GO:0055119) | 3.92902624 |
| 91 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.90413710 |
| 92 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.90291145 |
| 93 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.90094059 |
| 94 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 3.88990443 |
| 95 | potassium ion homeostasis (GO:0055075) | 3.88229320 |
| 96 | retinal cone cell development (GO:0046549) | 3.85525139 |
| 97 | relaxation of muscle (GO:0090075) | 3.85203216 |
| 98 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.81464806 |
| 99 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.81464806 |
| 100 | carnitine transmembrane transport (GO:1902603) | 3.78236675 |
| 101 | synaptic vesicle exocytosis (GO:0016079) | 3.77249169 |
| 102 | positive regulation of glomerulus development (GO:0090193) | 3.76234871 |
| 103 | cardiac muscle contraction (GO:0060048) | 3.75740130 |
| 104 | actomyosin structure organization (GO:0031032) | 3.74933118 |
| 105 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.70072463 |
| 106 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.69816809 |
| 107 | positive regulation of amino acid transport (GO:0051957) | 3.69411712 |
| 108 | muscle adaptation (GO:0043500) | 3.69138410 |
| 109 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 3.66839536 |
| 110 | tricarboxylic acid cycle (GO:0006099) | 3.61211150 |
| 111 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.59870821 |
| 112 | negative regulation of muscle hypertrophy (GO:0014741) | 3.56882574 |
| 113 | auditory receptor cell stereocilium organization (GO:0060088) | 3.56215287 |
| 114 | regulation of cofactor metabolic process (GO:0051193) | 3.55883216 |
| 115 | regulation of coenzyme metabolic process (GO:0051196) | 3.55883216 |
| 116 | regulation of potassium ion transmembrane transport (GO:1901379) | 3.54620253 |
| 117 | innervation (GO:0060384) | 3.53943015 |
| 118 | muscle cell cellular homeostasis (GO:0046716) | 3.53098106 |
| 119 | layer formation in cerebral cortex (GO:0021819) | 3.51992719 |
| 120 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.51916645 |
| 121 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.51728135 |
| 122 | long-term memory (GO:0007616) | 3.51391113 |
| 123 | membrane depolarization during action potential (GO:0086010) | 3.50796563 |
| 124 | long term synaptic depression (GO:0060292) | 3.50527718 |
| 125 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.49577354 |
| 126 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.46807782 |
| 127 | carnitine transport (GO:0015879) | 3.45806460 |
| 128 | amino-acid betaine transport (GO:0015838) | 3.45806460 |
| 129 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.45421125 |
| 130 | serotonin metabolic process (GO:0042428) | 3.43253140 |
| 131 | neuromuscular junction development (GO:0007528) | 3.41936314 |
| 132 | transmission of nerve impulse (GO:0019226) | 3.40291199 |
| 133 | dopamine biosynthetic process (GO:0042416) | 3.39256636 |
| 134 | cellular carbohydrate catabolic process (GO:0044275) | 3.39053402 |
| 135 | NADH metabolic process (GO:0006734) | 3.37338430 |
| 136 | response to activity (GO:0014823) | 3.35978671 |
| 137 | cGMP metabolic process (GO:0046068) | 3.34790649 |
| 138 | potassium ion import (GO:0010107) | 3.33974346 |
| 139 | acidic amino acid transport (GO:0015800) | 3.33844115 |
| 140 | succinate metabolic process (GO:0006105) | 3.32149866 |
| 141 | nephron tubule development (GO:0072080) | 3.30768858 |
| 142 | myotube differentiation (GO:0014902) | 3.29609524 |
| 143 | behavioral response to cocaine (GO:0048148) | 3.27837365 |
| 144 | response to water (GO:0009415) | 3.26386936 |
| 145 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.26064730 |
| 146 | parturition (GO:0007567) | 3.25199233 |
| 147 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.23210621 |
| 148 | regulation of postsynaptic membrane potential (GO:0060078) | 3.21774863 |
| 149 | cell communication by electrical coupling (GO:0010644) | 3.20289757 |
| 150 | sodium ion homeostasis (GO:0055078) | 3.17767085 |
| 151 | regulation of striated muscle contraction (GO:0006942) | 3.17176797 |
| 152 | regulation of actin filament-based movement (GO:1903115) | 3.16953970 |
| 153 | negative regulation of fatty acid transport (GO:2000192) | 3.16587264 |
| 154 | muscle organ development (GO:0007517) | 3.16256997 |
| 155 | synaptic vesicle maturation (GO:0016188) | 3.13572553 |
| 156 | response to ammonium ion (GO:0060359) | 3.13031234 |
| 157 | negative regulation of heart contraction (GO:0045822) | 3.12634962 |
| 158 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.11411437 |
| 159 | regulation of dopamine secretion (GO:0014059) | 3.11163259 |
| 160 | muscle structure development (GO:0061061) | 3.11107364 |
| 161 | membrane depolarization (GO:0051899) | 3.09191708 |
| 162 | striated muscle cell development (GO:0055002) | 3.08738904 |
| 163 | detection of calcium ion (GO:0005513) | 3.07703415 |
| 164 | regulation of amine transport (GO:0051952) | 3.06526403 |
| 165 | adult walking behavior (GO:0007628) | 3.05891946 |
| 166 | cellular potassium ion homeostasis (GO:0030007) | 3.04764813 |
| 167 | L-glutamate transport (GO:0015813) | 3.04240616 |
| 168 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.02294551 |
| 169 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.01939955 |
| 170 | negative regulation of catecholamine secretion (GO:0033604) | 3.01268382 |
| 171 | exploration behavior (GO:0035640) | 2.98421852 |
| 172 | endocrine hormone secretion (GO:0060986) | 2.98279329 |
| 173 | regulation of membrane repolarization (GO:0060306) | 2.98124698 |
| 174 | regulation of relaxation of muscle (GO:1901077) | 2.97798951 |
| 175 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.97138004 |
| 176 | positive regulation of cation channel activity (GO:2001259) | 2.96394669 |
| 177 | primary amino compound metabolic process (GO:1901160) | 2.94325635 |
| 178 | cellular response to ammonium ion (GO:0071242) | 2.93966897 |
| 179 | regulation of cation channel activity (GO:2001257) | 2.93750362 |
| 180 | regulation of neurotransmitter secretion (GO:0046928) | 2.93701168 |
| 181 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 2.93434708 |
| 182 | cellular response to dexamethasone stimulus (GO:0071549) | 2.91843740 |
| 183 | endoplasmic reticulum organization (GO:0007029) | 2.91235556 |
| 184 | IMP biosynthetic process (GO:0006188) | 2.90133610 |
| 185 | cerebellar granule cell differentiation (GO:0021707) | 2.87829119 |
| 186 | skeletal muscle tissue development (GO:0007519) | 2.86213409 |
| 187 | regulation of sequestering of calcium ion (GO:0051282) | 2.82899151 |
| 188 | regulation of sulfur metabolic process (GO:0042762) | 2.82675661 |
| 189 | calcium ion import (GO:0070509) | 2.82406863 |
| 190 | regulation of skeletal muscle contraction (GO:0014819) | 10.6675693 |
| 191 | actin-myosin filament sliding (GO:0033275) | 10.4402085 |
| 192 | muscle filament sliding (GO:0030049) | 10.4402085 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.49572450 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.31244835 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.03068629 |
| 4 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.97654316 |
| 5 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.94948552 |
| 6 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.91966836 |
| 7 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.79657325 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.53918189 |
| 9 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.52551817 |
| 10 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.49922159 |
| 11 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.46189717 |
| 12 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.41262213 |
| 13 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.35308088 |
| 14 | * CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.34839513 |
| 15 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.24153945 |
| 16 | SMAD4_21799915_ChIP-Seq_A2780_Human | 2.20766239 |
| 17 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.16587681 |
| 18 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.11071183 |
| 19 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.09438573 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.04082731 |
| 21 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.03185174 |
| 22 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.02294629 |
| 23 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.02294629 |
| 24 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.00434582 |
| 25 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.98658770 |
| 26 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.98598964 |
| 27 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.93660098 |
| 28 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.93211577 |
| 29 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.93175281 |
| 30 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.90186527 |
| 31 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.89422331 |
| 32 | FUS_26573619_Chip-Seq_HEK293_Human | 1.88581203 |
| 33 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.87327430 |
| 34 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.85849604 |
| 35 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.85577607 |
| 36 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.85387195 |
| 37 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.82437371 |
| 38 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.82303547 |
| 39 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.80651658 |
| 40 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.77874766 |
| 41 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.72425040 |
| 42 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.72171560 |
| 43 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.68792864 |
| 44 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.68463719 |
| 45 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.67202207 |
| 46 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.60974150 |
| 47 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.59714192 |
| 48 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.59714192 |
| 49 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.57905640 |
| 50 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.56933321 |
| 51 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.55471196 |
| 52 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.54884214 |
| 53 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.54802771 |
| 54 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.54762349 |
| 55 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.53639213 |
| 56 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.48553112 |
| 57 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.47129582 |
| 58 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.42564282 |
| 59 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.40920228 |
| 60 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.40233794 |
| 61 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.39826264 |
| 62 | TCF4_23295773_ChIP-Seq_U87_Human | 1.39612919 |
| 63 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.38753683 |
| 64 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.38724062 |
| 65 | P300_19829295_ChIP-Seq_ESCs_Human | 1.36898799 |
| 66 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.33270853 |
| 67 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.29068419 |
| 68 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.26198967 |
| 69 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.24395124 |
| 70 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.23452890 |
| 71 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23038345 |
| 72 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.22918470 |
| 73 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.22464209 |
| 74 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.21793201 |
| 75 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.21584289 |
| 76 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.20713667 |
| 77 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.20399145 |
| 78 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.19103317 |
| 79 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.17757201 |
| 80 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.17090026 |
| 81 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.17069233 |
| 82 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.16025059 |
| 83 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.14693956 |
| 84 | STAT3_23295773_ChIP-Seq_U87_Human | 1.14486486 |
| 85 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.13983201 |
| 86 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.13921451 |
| 87 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.13805009 |
| 88 | KDM2B_26808549_Chip-Seq_K562_Human | 1.13628744 |
| 89 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12686047 |
| 90 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.11928212 |
| 91 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.10617753 |
| 92 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.09740852 |
| 93 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.08928112 |
| 94 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.08436773 |
| 95 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.08432240 |
| 96 | SA1_27219007_Chip-Seq_Bcells_Human | 1.08157806 |
| 97 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.06645207 |
| 98 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.04612873 |
| 99 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.03998690 |
| 100 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.03616547 |
| 101 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.01243884 |
| 102 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.00780987 |
| 103 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.00589970 |
| 104 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.00589970 |
| 105 | RXR_22108803_ChIP-Seq_LS180_Human | 1.00198653 |
| 106 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.00037583 |
| 107 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.99498420 |
| 108 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.99334601 |
| 109 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.99306146 |
| 110 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.98440590 |
| 111 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.97252300 |
| 112 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.96980577 |
| 113 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96557068 |
| 114 | JUN_21703547_ChIP-Seq_K562_Human | 0.95238808 |
| 115 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.94581475 |
| 116 | AR_25329375_ChIP-Seq_VCAP_Human | 0.94013977 |
| 117 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.93716389 |
| 118 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.93461183 |
| 119 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.93302873 |
| 120 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.92794008 |
| 121 | AR_19668381_ChIP-Seq_PC3_Human | 0.92292004 |
| 122 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.92143758 |
| 123 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.92057926 |
| 124 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91134656 |
| 125 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.90908067 |
| 126 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.90382846 |
| 127 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.89635726 |
| 128 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.89381678 |
| 129 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.89339369 |
| 130 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.89195536 |
| 131 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.88762697 |
| 132 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.88491200 |
| 133 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.87624039 |
| 134 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.87365674 |
| 135 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.87312304 |
| 136 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.86686135 |
| 137 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.86587952 |
| 138 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.86399569 |
| 139 | VDR_22108803_ChIP-Seq_LS180_Human | 0.86225146 |
| 140 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.85868391 |
| 141 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.85214603 |
| 142 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.84772316 |
| 143 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.84581965 |
| 144 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.82164597 |
| 145 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.82160119 |
| 146 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.80962163 |
| 147 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.80900404 |
| 148 | P68_20966046_ChIP-Seq_HELA_Human | 0.80031518 |
| 149 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.79496141 |
| 150 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.79496141 |
| 151 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.79180271 |
| 152 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.79076890 |
| 153 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.78658055 |
| 154 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.78462245 |
| 155 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.77709049 |
| 156 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.76801597 |
| 157 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.76727463 |
| 158 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.76435745 |
| 159 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76048121 |
| 160 | MNX1_26342078_ChIP-Seq_MIN6-4N_Mouse | 0.75648032 |
| 161 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.75460832 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 8.42253578 |
| 2 | MP0003646_muscle_fatigue | 6.04940879 |
| 3 | MP0000749_muscle_degeneration | 5.84622971 |
| 4 | MP0000751_myopathy | 5.27360722 |
| 5 | MP0004742_abnormal_vestibular_system | 5.19497255 |
| 6 | MP0010386_abnormal_urinary_bladder | 4.47477599 |
| 7 | MP0000747_muscle_weakness | 4.31089698 |
| 8 | MP0004036_abnormal_muscle_relaxation | 3.95141673 |
| 9 | MP0002106_abnormal_muscle_physiology | 3.94222710 |
| 10 | MP0000759_abnormal_skeletal_muscle | 3.55108708 |
| 11 | MP0001984_abnormal_olfaction | 3.35300223 |
| 12 | MP0005369_muscle_phenotype | 3.31581968 |
| 13 | MP0002269_muscular_atrophy | 3.26092661 |
| 14 | MP0002837_dystrophic_cardiac_calcinosis | 3.15752963 |
| 15 | MP0004130_abnormal_muscle_cell | 3.11643263 |
| 16 | MP0001968_abnormal_touch/_nociception | 3.06549254 |
| 17 | MP0004087_abnormal_muscle_fiber | 3.05861097 |
| 18 | * MP0005620_abnormal_muscle_contractility | 2.80393848 |
| 19 | MP0000750_abnormal_muscle_regeneration | 2.66762807 |
| 20 | MP0002638_abnormal_pupillary_reflex | 2.66346144 |
| 21 | MP0004233_abnormal_muscle_weight | 2.64466496 |
| 22 | MP0008875_abnormal_xenobiotic_pharmacok | 2.41116699 |
| 23 | MP0002332_abnormal_exercise_endurance | 2.20507489 |
| 24 | MP0002735_abnormal_chemical_nociception | 2.20096680 |
| 25 | MP0005423_abnormal_somatic_nervous | 2.17018000 |
| 26 | MP0004270_analgesia | 2.16306549 |
| 27 | MP0008874_decreased_physiological_sensi | 2.14434046 |
| 28 | MP0002108_abnormal_muscle_morphology | 1.92527643 |
| 29 | MP0000733_abnormal_muscle_development | 1.91719880 |
| 30 | MP0004859_abnormal_synaptic_plasticity | 1.87857994 |
| 31 | MP0006036_abnormal_mitochondrial_physio | 1.83658481 |
| 32 | MP0002736_abnormal_nociception_after | 1.70480644 |
| 33 | MP0001970_abnormal_pain_threshold | 1.67329282 |
| 34 | MP0006276_abnormal_autonomic_nervous | 1.62739417 |
| 35 | MP0009046_muscle_twitch | 1.55532197 |
| 36 | MP0008569_lethality_at_weaning | 1.54626386 |
| 37 | MP0008872_abnormal_physiological_respon | 1.52019042 |
| 38 | MP0005330_cardiomyopathy | 1.48402630 |
| 39 | MP0003011_delayed_dark_adaptation | 1.48181466 |
| 40 | MP0002557_abnormal_social/conspecific_i | 1.44318007 |
| 41 | MP0004215_abnormal_myocardial_fiber | 1.43605830 |
| 42 | MP0003787_abnormal_imprinting | 1.43301606 |
| 43 | MP0004147_increased_porphyrin_level | 1.41195076 |
| 44 | MP0004084_abnormal_cardiac_muscle | 1.39807177 |
| 45 | MP0000013_abnormal_adipose_tissue | 1.37385581 |
| 46 | MP0004185_abnormal_adipocyte_glucose | 1.36615452 |
| 47 | MP0004484_altered_response_of | 1.29060153 |
| 48 | MP0002971_abnormal_brown_adipose | 1.27439604 |
| 49 | MP0002733_abnormal_thermal_nociception | 1.23475220 |
| 50 | MP0000566_synostosis | 1.19998461 |
| 51 | MP0005410_abnormal_fertilization | 1.19087438 |
| 52 | MP0000920_abnormal_myelination | 1.14991681 |
| 53 | MP0003635_abnormal_synaptic_transmissio | 1.14178741 |
| 54 | MP0002229_neurodegeneration | 1.13461794 |
| 55 | MP0002972_abnormal_cardiac_muscle | 1.12024453 |
| 56 | MP0005666_abnormal_adipose_tissue | 1.10113838 |
| 57 | MP0004142_abnormal_muscle_tone | 1.08743171 |
| 58 | MP0004043_abnormal_pH_regulation | 1.06886158 |
| 59 | MP0001485_abnormal_pinna_reflex | 1.06255533 |
| 60 | * MP0002882_abnormal_neuron_morphology | 1.05005312 |
| 61 | MP0003122_maternal_imprinting | 0.97966855 |
| 62 | MP0005266_abnormal_metabolism | 0.94599314 |
| 63 | MP0002272_abnormal_nervous_system | 0.93851578 |
| 64 | MP0003137_abnormal_impulse_conducting | 0.88326091 |
| 65 | MP0005551_abnormal_eye_electrophysiolog | 0.87999242 |
| 66 | MP0002067_abnormal_sensory_capabilities | 0.87401024 |
| 67 | MP0002734_abnormal_mechanical_nocicepti | 0.87233454 |
| 68 | MP0001440_abnormal_grooming_behavior | 0.86243496 |
| 69 | MP0001299_abnormal_eye_distance/ | 0.86096574 |
| 70 | MP0005375_adipose_tissue_phenotype | 0.86094041 |
| 71 | MP0005275_abnormal_skin_tensile | 0.85882119 |
| 72 | MP0003221_abnormal_cardiomyocyte_apopto | 0.85140665 |
| 73 | MP0003656_abnormal_erythrocyte_physiolo | 0.84877966 |
| 74 | MP0006072_abnormal_retinal_apoptosis | 0.83420088 |
| 75 | MP0010630_abnormal_cardiac_muscle | 0.83388496 |
| 76 | MP0000569_abnormal_digit_pigmentation | 0.83209394 |
| 77 | MP0009745_abnormal_behavioral_response | 0.83059885 |
| 78 | MP0002064_seizures | 0.81255506 |
| 79 | MP0008877_abnormal_DNA_methylation | 0.78592305 |
| 80 | MP0000343_altered_response_to | 0.77709341 |
| 81 | MP0004134_abnormal_chest_morphology | 0.77668814 |
| 82 | MP0001188_hyperpigmentation | 0.76705981 |
| 83 | MP0003705_abnormal_hypodermis_morpholog | 0.76393689 |
| 84 | MP0005623_abnormal_meninges_morphology | 0.76105921 |
| 85 | MP0009697_abnormal_copulation | 0.75242767 |
| 86 | MP0001502_abnormal_circadian_rhythm | 0.75163021 |
| 87 | MP0001765_abnormal_ion_homeostasis | 0.74891974 |
| 88 | MP0000372_irregular_coat_pigmentation | 0.72801161 |
| 89 | MP0003806_abnormal_nucleotide_metabolis | 0.72498940 |
| 90 | MP0005083_abnormal_biliary_tract | 0.70406433 |
| 91 | MP0002277_abnormal_respiratory_mucosa | 0.68954226 |
| 92 | MP0002066_abnormal_motor_capabilities/c | 0.68838648 |
| 93 | MP0003123_paternal_imprinting | 0.68406414 |
| 94 | * MP0002152_abnormal_brain_morphology | 0.67737635 |
| 95 | MP0008961_abnormal_basal_metabolism | 0.67635782 |
| 96 | MP0000230_abnormal_systemic_arterial | 0.67286574 |
| 97 | MP0002089_abnormal_postnatal_growth/wei | 0.67219320 |
| 98 | MP0005595_abnormal_vascular_smooth | 0.65946773 |
| 99 | MP0001544_abnormal_cardiovascular_syste | 0.65521942 |
| 100 | MP0005385_cardiovascular_system_phenoty | 0.65521942 |
| 101 | MP0002063_abnormal_learning/memory/cond | 0.65472574 |
| 102 | MP0005646_abnormal_pituitary_gland | 0.62950171 |
| 103 | MP0009379_abnormal_foot_pigmentation | 0.61421369 |
| 104 | MP0000003_abnormal_adipose_tissue | 0.60308661 |
| 105 | MP0001963_abnormal_hearing_physiology | 0.58942296 |
| 106 | MP0002234_abnormal_pharynx_morphology | 0.57769268 |
| 107 | MP0009250_abnormal_appendicular_skeleto | 0.57483732 |
| 108 | MP0003329_amyloid_beta_deposits | 0.56897054 |
| 109 | * MP0006035_abnormal_mitochondrial_morpho | 0.56597375 |
| 110 | MP0003868_abnormal_feces_composition | 0.56557477 |
| 111 | MP0002184_abnormal_innervation | 0.56403757 |
| 112 | MP0002078_abnormal_glucose_homeostasis | 0.55945885 |
| 113 | MP0002090_abnormal_vision | 0.54633506 |
| 114 | MP0000534_abnormal_ureter_morphology | 0.52847834 |
| 115 | MP0003950_abnormal_plasma_membrane | 0.52475925 |
| 116 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.52071199 |
| 117 | MP0001986_abnormal_taste_sensitivity | 0.51807485 |
| 118 | MP0001501_abnormal_sleep_pattern | 0.50642263 |
| 119 | MP0000955_abnormal_spinal_cord | 0.49491649 |
| 120 | MP0001756_abnormal_urination | 0.49397905 |
| 121 | MP0010329_abnormal_lipoprotein_level | 0.49345317 |
| 122 | MP0001486_abnormal_startle_reflex | 0.49084751 |
| 123 | MP0002752_abnormal_somatic_nervous | 0.48289962 |
| 124 | MP0003045_fibrosis | 0.47757657 |
| 125 | MP0002083_premature_death | 0.46747386 |
| 126 | MP0000762_abnormal_tongue_morphology | 0.46461585 |
| 127 | MP0003956_abnormal_body_size | 0.46371452 |
| 128 | MP0000579_abnormal_nail_morphology | 0.45521065 |
| 129 | MP0005464_abnormal_platelet_physiology | 0.45505907 |
| 130 | MP0005334_abnormal_fat_pad | 0.45385071 |
| 131 | MP0003638_abnormal_response/metabolism_ | 0.44791172 |
| 132 | MP0003879_abnormal_hair_cell | 0.44481188 |
| 133 | MP0002909_abnormal_adrenal_gland | 0.44428559 |
| 134 | MP0001177_atelectasis | 0.44419865 |
| 135 | MP0004858_abnormal_nervous_system | 0.44369208 |
| 136 | MP0000538_abnormal_urinary_bladder | 0.43400143 |
| 137 | MP0008775_abnormal_heart_ventricle | 0.43258955 |
| 138 | MP0005253_abnormal_eye_physiology | 0.43045122 |
| 139 | MP0005174_abnormal_tail_pigmentation | 0.42775627 |
| 140 | MP0005452_abnormal_adipose_tissue | 0.42251652 |
| 141 | MP0003633_abnormal_nervous_system | 0.41523025 |
| 142 | MP0009780_abnormal_chondrocyte_physiolo | 0.40972977 |
| 143 | MP0002572_abnormal_emotion/affect_behav | 0.40493283 |
| 144 | MP0002822_catalepsy | 0.40174264 |
| 145 | MP0005535_abnormal_body_temperature | 0.39849831 |
| 146 | MP0004085_abnormal_heartbeat | 0.38743330 |
| 147 | MP0002896_abnormal_bone_mineralization | 0.37584293 |
| 148 | MP0001943_abnormal_respiration | 0.36875842 |
| 149 | MP0002796_impaired_skin_barrier | 0.36262965 |
| 150 | MP0003880_abnormal_central_pattern | 0.35329101 |
| 151 | MP0004811_abnormal_neuron_physiology | 0.34913249 |
| 152 | MP0004924_abnormal_behavior | 0.33762362 |
| 153 | MP0005386_behavior/neurological_phenoty | 0.33762362 |
| 154 | MP0006138_congestive_heart_failure | 0.33640366 |
| 155 | MP0003631_nervous_system_phenotype | 0.33493920 |
| 156 | MP0003959_abnormal_lean_body | 0.33096577 |
| 157 | MP0000266_abnormal_heart_morphology | 0.32693947 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Action tremor (HP:0002345) | 8.98589486 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 8.93977815 |
| 3 | Exercise-induced myalgia (HP:0003738) | 8.93960058 |
| 4 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 8.66518634 |
| 5 | Scanning speech (HP:0002168) | 8.60180968 |
| 6 | Myokymia (HP:0002411) | 8.36754499 |
| 7 | Exercise-induced muscle cramps (HP:0003710) | 8.25564007 |
| 8 | Dysmetric saccades (HP:0000641) | 8.25332569 |
| 9 | Nemaline bodies (HP:0003798) | 8.13692975 |
| 10 | Distal arthrogryposis (HP:0005684) | 7.05983354 |
| 11 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.65997221 |
| 12 | Myopathic facies (HP:0002058) | 6.58233115 |
| 13 | Type 1 muscle fiber predominance (HP:0003803) | 6.56813885 |
| 14 | Dysdiadochokinesis (HP:0002075) | 6.49135429 |
| 15 | Progressive cerebellar ataxia (HP:0002073) | 6.40723258 |
| 16 | Epileptic encephalopathy (HP:0200134) | 6.38851144 |
| 17 | Round ear (HP:0100830) | 6.34637186 |
| 18 | Horizontal nystagmus (HP:0000666) | 6.18563444 |
| 19 | Ulnar deviation of the wrist (HP:0003049) | 6.17267753 |
| 20 | Dialeptic seizures (HP:0011146) | 5.98604210 |
| 21 | Gaze-evoked nystagmus (HP:0000640) | 5.75507977 |
| 22 | Postural tremor (HP:0002174) | 5.74933182 |
| 23 | Calf muscle hypertrophy (HP:0008981) | 5.72620607 |
| 24 | Difficulty running (HP:0009046) | 5.37232047 |
| 25 | Myoglobinuria (HP:0002913) | 5.29331882 |
| 26 | Calcaneovalgus deformity (HP:0001848) | 5.29207529 |
| 27 | Intention tremor (HP:0002080) | 5.16530969 |
| 28 | Truncal ataxia (HP:0002078) | 5.13488752 |
| 29 | Focal seizures (HP:0007359) | 5.13401127 |
| 30 | Absent phalangeal crease (HP:0006109) | 5.02465685 |
| 31 | Muscle stiffness (HP:0003552) | 4.98023221 |
| 32 | Deformed tarsal bones (HP:0008119) | 4.96271428 |
| 33 | Impaired vibration sensation in the lower limbs (HP:0002166) | 4.84402584 |
| 34 | Dysmetria (HP:0001310) | 4.77182397 |
| 35 | Muscle fiber splitting (HP:0003555) | 4.76430027 |
| 36 | Myotonia (HP:0002486) | 4.54113084 |
| 37 | Hyporeflexia of lower limbs (HP:0002600) | 4.47835063 |
| 38 | Impaired smooth pursuit (HP:0007772) | 4.41677990 |
| 39 | Abnormal finger flexion creases (HP:0006143) | 4.28161080 |
| 40 | EMG: myopathic abnormalities (HP:0003458) | 4.28158153 |
| 41 | Rhabdomyolysis (HP:0003201) | 4.26941345 |
| 42 | Increased connective tissue (HP:0009025) | 4.05729975 |
| 43 | Abnormality of saccadic eye movements (HP:0000570) | 3.89337500 |
| 44 | Abnormality of the calf musculature (HP:0001430) | 3.78371237 |
| 45 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.74176839 |
| 46 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.74123909 |
| 47 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.74123909 |
| 48 | Abnormality of ocular smooth pursuit (HP:0000617) | 3.73135196 |
| 49 | Generalized tonic-clonic seizures (HP:0002069) | 3.54307200 |
| 50 | Increased variability in muscle fiber diameter (HP:0003557) | 3.40332369 |
| 51 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.39965488 |
| 52 | Subaortic stenosis (HP:0001682) | 3.39965488 |
| 53 | Acute necrotizing encephalopathy (HP:0006965) | 3.37162088 |
| 54 | Shoulder girdle muscle weakness (HP:0003547) | 3.28352521 |
| 55 | Malignant hyperthermia (HP:0002047) | 3.27306252 |
| 56 | Neck muscle weakness (HP:0000467) | 3.25287790 |
| 57 | Limb ataxia (HP:0002070) | 3.22614738 |
| 58 | Rimmed vacuoles (HP:0003805) | 3.16378559 |
| 59 | Pelvic girdle muscle weakness (HP:0003749) | 3.15708758 |
| 60 | Abnormality of the corticospinal tract (HP:0002492) | 3.09517356 |
| 61 | Abnormality of the calcaneus (HP:0008364) | 3.08338512 |
| 62 | Abnormality of the hip-girdle musculature (HP:0001445) | 3.07996171 |
| 63 | Abnormality of the musculature of the pelvis (HP:0001469) | 3.07996171 |
| 64 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.05181517 |
| 65 | Difficulty climbing stairs (HP:0003551) | 3.04634932 |
| 66 | Hyperlipoproteinemia (HP:0010980) | 3.04338370 |
| 67 | Frequent falls (HP:0002359) | 2.99669116 |
| 68 | Hyperkalemia (HP:0002153) | 2.97519473 |
| 69 | Impaired vibratory sensation (HP:0002495) | 2.93726177 |
| 70 | Areflexia of lower limbs (HP:0002522) | 2.93523930 |
| 71 | Progressive macrocephaly (HP:0004481) | 2.91647108 |
| 72 | Gait ataxia (HP:0002066) | 2.80401013 |
| 73 | Status epilepticus (HP:0002133) | 2.71306320 |
| 74 | Asymmetric septal hypertrophy (HP:0001670) | 2.66465140 |
| 75 | Focal dystonia (HP:0004373) | 2.65739571 |
| 76 | Acute encephalopathy (HP:0006846) | 2.65663168 |
| 77 | Paralysis (HP:0003470) | 2.54277289 |
| 78 | EMG: neuropathic changes (HP:0003445) | 2.47587552 |
| 79 | Sudden death (HP:0001699) | 2.47060724 |
| 80 | Slender build (HP:0001533) | 2.46423275 |
| 81 | Mitochondrial inheritance (HP:0001427) | 2.44158110 |
| 82 | Nonprogressive disorder (HP:0003680) | 2.41056268 |
| 83 | Fatigable weakness (HP:0003473) | 2.35748435 |
| 84 | Abnormality of the neuromuscular junction (HP:0003398) | 2.35748435 |
| 85 | Diplopia (HP:0000651) | 2.33331135 |
| 86 | Abnormality of binocular vision (HP:0011514) | 2.33331135 |
| 87 | Depression (HP:0000716) | 2.31979288 |
| 88 | Autoamputation (HP:0001218) | 2.29336779 |
| 89 | Focal motor seizures (HP:0011153) | 2.28427385 |
| 90 | Muscular dystrophy (HP:0003560) | 2.28237133 |
| 91 | Distal lower limb muscle weakness (HP:0009053) | 2.22697364 |
| 92 | Insidious onset (HP:0003587) | 2.15114551 |
| 93 | Termporal pattern (HP:0011008) | 2.15114551 |
| 94 | Cerebellar atrophy (HP:0001272) | 2.13762937 |
| 95 | Slow progression (HP:0003677) | 2.13056908 |
| 96 | Ulnar deviation of finger (HP:0009465) | 2.11484085 |
| 97 | Limb-girdle muscle weakness (HP:0003325) | 2.10719074 |
| 98 | Proximal amyotrophy (HP:0007126) | 2.09514055 |
| 99 | Hemiplegia (HP:0002301) | 2.07793136 |
| 100 | Achilles tendon contracture (HP:0001771) | 2.01774208 |
| 101 | Amblyopia (HP:0000646) | 2.00719760 |
| 102 | Metatarsus adductus (HP:0001840) | 1.99975213 |
| 103 | Bulbar palsy (HP:0001283) | 1.99515712 |
| 104 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.99454355 |
| 105 | Hypoplastic ischia (HP:0003175) | 1.99145509 |
| 106 | Generalized muscle weakness (HP:0003324) | 1.98317954 |
| 107 | Atonic seizures (HP:0010819) | 1.96211210 |
| 108 | Epileptiform EEG discharges (HP:0011182) | 1.95966359 |
| 109 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.93774281 |
| 110 | Athetosis (HP:0002305) | 1.93405263 |
| 111 | Increased hepatocellular lipid droplets (HP:0006565) | 1.92469352 |
| 112 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.90733355 |
| 113 | Dysarthria (HP:0001260) | 1.90709330 |
| 114 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.89635938 |
| 115 | Facial diplegia (HP:0001349) | 1.89481569 |
| 116 | Cerebral edema (HP:0002181) | 1.87297720 |
| 117 | Limb-girdle muscle atrophy (HP:0003797) | 1.87225776 |
| 118 | Gout (HP:0001997) | 1.86692239 |
| 119 | Cholelithiasis (HP:0001081) | 1.85890354 |
| 120 | EEG with generalized epileptiform discharges (HP:0011198) | 1.85377532 |
| 121 | Fetal akinesia sequence (HP:0001989) | 1.84905321 |
| 122 | Increased serum pyruvate (HP:0003542) | 1.83940819 |
| 123 | Abnormality of the Achilles tendon (HP:0005109) | 1.82972517 |
| 124 | Spinal rigidity (HP:0003306) | 1.82962940 |
| 125 | Renal Fanconi syndrome (HP:0001994) | 1.82357726 |
| 126 | Increased CSF lactate (HP:0002490) | 1.82232852 |
| 127 | Gowers sign (HP:0003391) | 1.80892689 |
| 128 | Degeneration of anterior horn cells (HP:0002398) | 1.79167481 |
| 129 | Abnormality of the anterior horn cell (HP:0006802) | 1.79167481 |
| 130 | Scapular winging (HP:0003691) | 1.78281542 |
| 131 | Increased purine levels (HP:0004368) | 1.75827015 |
| 132 | Hyperuricemia (HP:0002149) | 1.75827015 |
| 133 | Hemiparesis (HP:0001269) | 1.75463335 |
| 134 | Tarsal synostosis (HP:0008368) | 1.75180396 |
| 135 | Abnormality of the ischium (HP:0003174) | 1.74335631 |
| 136 | Oligomenorrhea (HP:0000876) | 1.74162581 |
| 137 | Visual hallucinations (HP:0002367) | 1.71856146 |
| 138 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.68420150 |
| 139 | Urinary urgency (HP:0000012) | 1.67126485 |
| 140 | Abnormality of glycolysis (HP:0004366) | 1.66841915 |
| 141 | Absence seizures (HP:0002121) | 1.66800450 |
| 142 | Waddling gait (HP:0002515) | 1.66486117 |
| 143 | Distal lower limb amyotrophy (HP:0008944) | 1.64679028 |
| 144 | Abnormal gallbladder morphology (HP:0012437) | 1.63626843 |
| 145 | Leukodystrophy (HP:0002415) | 1.63316316 |
| 146 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.61427937 |
| 147 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.60818074 |
| 148 | Synostosis involving bones of the feet (HP:0009140) | 1.60818074 |
| 149 | Broad-based gait (HP:0002136) | 1.60781593 |
| 150 | Esotropia (HP:0000565) | 1.59442549 |
| 151 | Abnormality of potassium homeostasis (HP:0011042) | 1.59158772 |
| 152 | Weak cry (HP:0001612) | 1.58791565 |
| 153 | Incomplete penetrance (HP:0003829) | 1.57702511 |
| 154 | Aplasia involving bones of the extremities (HP:0009825) | 1.56309957 |
| 155 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.56309957 |
| 156 | Aplasia of the phalanges of the hand (HP:0009802) | 1.56309957 |
| 157 | Spastic gait (HP:0002064) | 1.55975920 |
| 158 | Stridor (HP:0010307) | 1.55832222 |
| 159 | Supranuclear gaze palsy (HP:0000605) | 1.55824197 |
| 160 | Lipid accumulation in hepatocytes (HP:0006561) | 1.55548956 |
| 161 | Choroideremia (HP:0001139) | 1.53576468 |
| 162 | Exercise intolerance (HP:0003546) | 1.52046388 |
| 163 | Progressive muscle weakness (HP:0003323) | 1.51621503 |
| 164 | Increased intramyocellular lipid droplets (HP:0012240) | 1.51492641 |
| 165 | Intellectual disability, mild (HP:0001256) | 1.47863930 |
| 166 | Increased density of long bones (HP:0006392) | 1.47591083 |
| 167 | Adducted thumb (HP:0001181) | 1.47083360 |
| 168 | Heterochromia iridis (HP:0001100) | 1.46275608 |
| 169 | Congenital hip dislocation (HP:0001374) | 1.45900792 |
| 170 | Febrile seizures (HP:0002373) | 1.45874637 |
| 171 | Bundle branch block (HP:0011710) | 1.45211090 |
| 172 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.44604858 |
| 173 | Syncope (HP:0001279) | 1.44311276 |
| 174 | X-linked dominant inheritance (HP:0001423) | 1.42570850 |
| 175 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.41271280 |
| 176 | Optic disc pallor (HP:0000543) | 1.37308069 |
| 177 | Epidermoid cyst (HP:0200040) | 1.34574903 |
| 178 | Skin nodule (HP:0200036) | 1.32210145 |
| 179 | Anxiety (HP:0000739) | 1.31066757 |
| 180 | Lower limb amyotrophy (HP:0007210) | 1.30714426 |
| 181 | Abnormal eating behavior (HP:0100738) | 1.28240215 |
| 182 | Postural instability (HP:0002172) | 1.27715628 |
| 183 | Lower limb muscle weakness (HP:0007340) | 1.27107855 |
| 184 | Rigidity (HP:0002063) | 1.26612905 |
| 185 | Ankle clonus (HP:0011448) | 1.25178184 |
| 186 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.22695813 |
| 187 | Exertional dyspnea (HP:0002875) | 1.22534990 |
| 188 | Dysphonia (HP:0001618) | 1.22362033 |
| 189 | Global brain atrophy (HP:0002283) | 1.22325930 |
| 190 | Sleep apnea (HP:0010535) | 1.21374279 |
| 191 | Progressive inability to walk (HP:0002505) | 1.21264187 |
| 192 | Hypsarrhythmia (HP:0002521) | 1.21124775 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.71665180 |
| 2 | PHKG1 | 5.97991986 |
| 3 | PHKG2 | 5.97991986 |
| 4 | TTN | 5.68734358 |
| 5 | NME1 | 4.42233663 |
| 6 | MYLK | 3.15174682 |
| 7 | PIK3CG | 3.04958718 |
| 8 | MAP2K3 | 2.81832128 |
| 9 | ARAF | 2.64007578 |
| 10 | NEK1 | 2.62784952 |
| 11 | PINK1 | 2.54321209 |
| 12 | MAP2K4 | 2.44394076 |
| 13 | CSNK1G2 | 2.20800541 |
| 14 | CSNK1G3 | 2.15253079 |
| 15 | CSNK1A1L | 2.07305666 |
| 16 | MAP3K7 | 2.02108357 |
| 17 | PDK3 | 1.96581965 |
| 18 | PDK4 | 1.96581965 |
| 19 | TTK | 1.89707867 |
| 20 | MAPK12 | 1.71265700 |
| 21 | CSNK1G1 | 1.66124201 |
| 22 | TRIB3 | 1.65162620 |
| 23 | EPHA4 | 1.63214795 |
| 24 | PIK3CA | 1.62395664 |
| 25 | MAP2K6 | 1.58563422 |
| 26 | PRKG2 | 1.53450103 |
| 27 | CASK | 1.51073982 |
| 28 | DAPK1 | 1.50940589 |
| 29 | TESK1 | 1.42635725 |
| 30 | MAP3K13 | 1.35751522 |
| 31 | DMPK | 1.34252473 |
| 32 | BCKDK | 1.29302751 |
| 33 | PDK2 | 1.29249439 |
| 34 | PAK4 | 1.21572741 |
| 35 | RIPK1 | 1.12311379 |
| 36 | BRAF | 1.07375878 |
| 37 | FYN | 1.01218244 |
| 38 | RIPK4 | 0.99004417 |
| 39 | MAP3K4 | 0.96955004 |
| 40 | DAPK3 | 0.91607674 |
| 41 | CAMKK2 | 0.89099375 |
| 42 | PRKAA1 | 0.88617426 |
| 43 | MUSK | 0.87559809 |
| 44 | PRKAA2 | 0.87364027 |
| 45 | CAMK2G | 0.86816110 |
| 46 | PLK2 | 0.82226191 |
| 47 | PRKCA | 0.81393915 |
| 48 | ERBB3 | 0.79905899 |
| 49 | NEK9 | 0.78090436 |
| 50 | PRKCE | 0.77504381 |
| 51 | WNK1 | 0.76477889 |
| 52 | NTRK3 | 0.76374538 |
| 53 | PAK6 | 0.75825363 |
| 54 | EIF2AK1 | 0.74730304 |
| 55 | KSR2 | 0.73648054 |
| 56 | MAPKAPK3 | 0.72982838 |
| 57 | TAOK2 | 0.71940987 |
| 58 | MAP3K9 | 0.70650888 |
| 59 | CSNK1A1 | 0.69529927 |
| 60 | CDK19 | 0.63779571 |
| 61 | CDK3 | 0.63636268 |
| 62 | TAOK1 | 0.62256438 |
| 63 | SCYL2 | 0.61652405 |
| 64 | PTK6 | 0.58806282 |
| 65 | STK24 | 0.56040007 |
| 66 | PNCK | 0.55468047 |
| 67 | MST4 | 0.54065796 |
| 68 | SRC | 0.52958963 |
| 69 | SGK1 | 0.52543398 |
| 70 | MINK1 | 0.52226624 |
| 71 | LIMK1 | 0.51558655 |
| 72 | STK38 | 0.51257962 |
| 73 | PRKDC | 0.50714379 |
| 74 | MAP3K12 | 0.50092283 |
| 75 | TRIM28 | 0.49318412 |
| 76 | CSNK1D | 0.49217757 |
| 77 | TRPM7 | 0.48521349 |
| 78 | CDK14 | 0.47704894 |
| 79 | MOS | 0.47383015 |
| 80 | MAP3K11 | 0.47051374 |
| 81 | FES | 0.46962354 |
| 82 | MAP3K3 | 0.46394762 |
| 83 | RAF1 | 0.45456906 |
| 84 | PRKCB | 0.45154835 |
| 85 | AKT3 | 0.44821548 |
| 86 | EPHB1 | 0.44267764 |
| 87 | CDK18 | 0.43693217 |
| 88 | MAPK11 | 0.43104225 |
| 89 | ITK | 0.42452707 |
| 90 | TAF1 | 0.42203267 |
| 91 | AKT2 | 0.42108533 |
| 92 | CAMKK1 | 0.41440966 |
| 93 | PRKCG | 0.41374780 |
| 94 | MAP2K7 | 0.40202727 |
| 95 | PRKG1 | 0.40133688 |
| 96 | CDK15 | 0.39962207 |
| 97 | RPS6KA3 | 0.39859671 |
| 98 | CAMK1G | 0.39796961 |
| 99 | MAP3K1 | 0.38213393 |
| 100 | CSNK1E | 0.38117392 |
| 101 | PDK1 | 0.37997162 |
| 102 | UHMK1 | 0.37775893 |
| 103 | PDPK1 | 0.35986398 |
| 104 | PRKACB | 0.35282516 |
| 105 | STK39 | 0.35022003 |
| 106 | PRKACA | 0.34804891 |
| 107 | SGK3 | 0.34087308 |
| 108 | RPS6KB1 | 0.33721409 |
| 109 | DAPK2 | 0.33334962 |
| 110 | STK11 | 0.32745948 |
| 111 | CDK11A | 0.31593028 |
| 112 | MARK1 | 0.29742453 |
| 113 | PAK3 | 0.29532184 |
| 114 | MAP3K6 | 0.29343473 |
| 115 | KSR1 | 0.28333548 |
| 116 | PRKCH | 0.27477110 |
| 117 | ILK | 0.26665748 |
| 118 | SIK1 | 0.26521270 |
| 119 | BMX | 0.26330198 |
| 120 | CCNB1 | 0.25501357 |
| 121 | SIK3 | 0.25065586 |
| 122 | OXSR1 | 0.24568193 |
| 123 | CAMK2D | 0.23706275 |
| 124 | PKN1 | 0.22907997 |
| 125 | MARK2 | 0.22617165 |
| 126 | CDK5 | 0.22323672 |
| 127 | MAP3K5 | 0.21654474 |
| 128 | PRKCZ | 0.20828376 |
| 129 | MAPK7 | 0.20757566 |
| 130 | WNK4 | 0.20485966 |
| 131 | SGK2 | 0.20272305 |
| 132 | MAP2K1 | 0.19943353 |
| 133 | TNK2 | 0.19675579 |
| 134 | ROCK2 | 0.19461041 |
| 135 | RET | 0.18900068 |
| 136 | CAMK1 | 0.18562099 |
| 137 | NTRK2 | 0.18378417 |
| 138 | PRKD1 | 0.18316210 |
| 139 | CAMK2A | 0.17777474 |
| 140 | SGK223 | 0.16489402 |
| 141 | SGK494 | 0.16489402 |
| 142 | LATS2 | 0.15879279 |
| 143 | PRKACG | 0.15277567 |
| 144 | ZAK | 0.14979674 |
| 145 | MAPK10 | 0.14037951 |
| 146 | CAMK4 | 0.13770060 |
| 147 | CAMK2B | 0.13295164 |
| 148 | MAPK4 | 0.13268196 |
| 149 | PKN2 | 0.13189740 |
| 150 | EEF2K | 0.12831359 |
| 151 | FER | 0.12808318 |
| 152 | GRK5 | 0.12069668 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.61247141 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.16987218 |
| 3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.01046330 |
| 4 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.74411452 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.71516165 |
| 6 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.50717841 |
| 7 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.37573910 |
| 8 | Circadian rhythm_Homo sapiens_hsa04710 | 2.21979806 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.08160242 |
| 10 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.03191520 |
| 11 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.99249875 |
| 12 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.94512248 |
| 13 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.93320172 |
| 14 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.77226496 |
| 15 | Alzheimers disease_Homo sapiens_hsa05010 | 1.74552089 |
| 16 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.71602069 |
| 17 | Parkinsons disease_Homo sapiens_hsa05012 | 1.68402940 |
| 18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.68179007 |
| 19 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.66034324 |
| 20 | Carbon metabolism_Homo sapiens_hsa01200 | 1.63544818 |
| 21 | Long-term depression_Homo sapiens_hsa04730 | 1.60179197 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.57455007 |
| 23 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.55027732 |
| 24 | Long-term potentiation_Homo sapiens_hsa04720 | 1.52775927 |
| 25 | Insulin resistance_Homo sapiens_hsa04931 | 1.51921944 |
| 26 | Nicotine addiction_Homo sapiens_hsa05033 | 1.51323945 |
| 27 | GABAergic synapse_Homo sapiens_hsa04727 | 1.43681299 |
| 28 | Circadian entrainment_Homo sapiens_hsa04713 | 1.41120485 |
| 29 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.39351249 |
| 30 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.36886611 |
| 31 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.34685941 |
| 32 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.32471483 |
| 33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.31047676 |
| 34 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.28674701 |
| 35 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.27684151 |
| 36 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.27666590 |
| 37 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.26542343 |
| 38 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.26325384 |
| 39 | Insulin secretion_Homo sapiens_hsa04911 | 1.16774425 |
| 40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.15489995 |
| 41 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.15011761 |
| 42 | Galactose metabolism_Homo sapiens_hsa00052 | 1.14227910 |
| 43 | Renin secretion_Homo sapiens_hsa04924 | 1.12243389 |
| 44 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.11090121 |
| 45 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.09771542 |
| 46 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.09190853 |
| 47 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.05801468 |
| 48 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.04395750 |
| 49 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.03778855 |
| 50 | Olfactory transduction_Homo sapiens_hsa04740 | 0.99760046 |
| 51 | Salivary secretion_Homo sapiens_hsa04970 | 0.98260844 |
| 52 | Tight junction_Homo sapiens_hsa04530 | 0.96787762 |
| 53 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.88455842 |
| 54 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.87686806 |
| 55 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.87041986 |
| 56 | Morphine addiction_Homo sapiens_hsa05032 | 0.84847539 |
| 57 | Huntingtons disease_Homo sapiens_hsa05016 | 0.81070722 |
| 58 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.80630664 |
| 59 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.80264229 |
| 60 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.79925358 |
| 61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.78396181 |
| 62 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.77901817 |
| 63 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.75448954 |
| 64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.74583013 |
| 65 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.74179271 |
| 66 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.73866762 |
| 67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.72583767 |
| 68 | Cocaine addiction_Homo sapiens_hsa05030 | 0.72378140 |
| 69 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.72016768 |
| 70 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.71580489 |
| 71 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.70697152 |
| 72 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.70498146 |
| 73 | Taste transduction_Homo sapiens_hsa04742 | 0.70019346 |
| 74 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.69026132 |
| 75 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.66926748 |
| 76 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.66697663 |
| 77 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.65285478 |
| 78 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.65064519 |
| 79 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.61377070 |
| 80 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60907763 |
| 81 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.60425168 |
| 82 | Focal adhesion_Homo sapiens_hsa04510 | 0.60035014 |
| 83 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.58399846 |
| 84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55192468 |
| 85 | Gap junction_Homo sapiens_hsa04540 | 0.54942581 |
| 86 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.53435187 |
| 87 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.51177462 |
| 88 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.50914410 |
| 89 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.50852926 |
| 90 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50197741 |
| 91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47526456 |
| 92 | Viral myocarditis_Homo sapiens_hsa05416 | 0.46072104 |
| 93 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.45144182 |
| 94 | Platelet activation_Homo sapiens_hsa04611 | 0.42902120 |
| 95 | Mineral absorption_Homo sapiens_hsa04978 | 0.42139561 |
| 96 | Melanogenesis_Homo sapiens_hsa04916 | 0.41734024 |
| 97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41313252 |
| 98 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.41193085 |
| 99 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.39308399 |
| 100 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.38512865 |
| 101 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37445317 |
| 102 | Bile secretion_Homo sapiens_hsa04976 | 0.35631680 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35537898 |
| 104 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.35268886 |
| 105 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.33808668 |
| 106 | Prion diseases_Homo sapiens_hsa05020 | 0.32506448 |
| 107 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.30578808 |
| 108 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.30004231 |
| 109 | Glioma_Homo sapiens_hsa05214 | 0.28783425 |
| 110 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.28048730 |
| 111 | Protein export_Homo sapiens_hsa03060 | 0.26166046 |
| 112 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.25775351 |
| 113 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.25625492 |
| 114 | Alcoholism_Homo sapiens_hsa05034 | 0.25578590 |
| 115 | Amoebiasis_Homo sapiens_hsa05146 | 0.25439002 |
| 116 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25259715 |
| 117 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.25158201 |
| 118 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.23772531 |
| 119 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.23675326 |
| 120 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.17021566 |
| 121 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.16228484 |
| 122 | Endocytosis_Homo sapiens_hsa04144 | 0.15700439 |
| 123 | Phototransduction_Homo sapiens_hsa04744 | 0.14740292 |
| 124 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.13679204 |
| 125 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.09139285 |
| 126 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.07020493 |
| 127 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.03862877 |
| 128 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.01322203 |
| 129 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.01223523 |

